Innopharma, Inc
Innopharma, Inc. was acquired by Pfizer, Inc on September 25, 2014. - InnoPharma, Inc. develops niche generic and specialty pharmaceutical/bio-pharmaceutical products in sterile dosage forms, and out-licenses to pharmaceutical marketing companies for commercialization. The “Niche Generics” program is targeted on developing those generic drug products that are: •Difficult to develop for technical reasons, especially injectable and ophthalmic dosage forms •None or very limited API source •Niche area of use •Complicated manufacturing •Complicated bio-equivalency or clinical studies •Potential to provide value to patients and prescribers, in terms of cost effectiveness Visit us at: http://innopharmainc.com
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
10
51 to 200 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Innopharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
Showing 1 of 7 verified contacts
Top roles at Innopharma, Inc
6 distinct titles indexed · top 6 shown.
- 1channel sales executive
- 1finance
- 1local country coordinator & member of medical direction
- 1masters
- 1medical representative
- 1sales manager
Sign up to unlock all 7 contacts at Innopharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Innopharma, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.